MULTIPLE SCLEROSIS, PRIMARY PROGRESSIVE
Clinical trials for MULTIPLE SCLEROSIS, PRIMARY PROGRESSIVE explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SCLEROSIS, PRIMARY PROGRESSIVE trials appear
Sign up with your email to follow new studies for MULTIPLE SCLEROSIS, PRIMARY PROGRESSIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a common supplement slow MS brain damage? new trial aims to find out
Disease control OngoingThis study tests whether N-acetyl cysteine (NAC), a supplement, can slow brain damage in people with progressive multiple sclerosis. About 98 adults with primary or secondary progressive MS will receive either NAC or a placebo for 15 months. Researchers will measure brain shrinka…
Matched conditions: MULTIPLE SCLEROSIS, PRIMARY PROGRESSIVE
Phase: PHASE2 • Sponsor: Emmanuelle Waubant, MD PhD • Aim: Disease control
Last updated May 26, 2026 09:35 UTC
-
New hope for progressive MS: drug aims to slow disability
Disease control OngoingThis study tests whether ocrelizumab (Ocrevus) can slow disability worsening in adults with primary progressive multiple sclerosis (PPMS), including those with more advanced disease. About 1,000 participants receive either the drug or a placebo, and researchers measure changes in…
Matched conditions: MULTIPLE SCLEROSIS, PRIMARY PROGRESSIVE
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 26, 2026 09:34 UTC
-
New daily pill takes on standard MS infusion in major disability battle
Disease control OngoingThis study compares two treatments for primary progressive multiple sclerosis (PPMS), a form of MS that steadily worsens over time. About 985 adults with PPMS received either a daily oral medication (fenebrutinib) or a twice-yearly intravenous infusion (ocrelizumab) to see which …
Matched conditions: MULTIPLE SCLEROSIS, PRIMARY PROGRESSIVE
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New study tracks brain decline in progressive MS patients
Knowledge-focused OngoingThis study follows 66 people with primary progressive multiple sclerosis (PPMS) and healthy volunteers for 2 years to see how thinking skills change. Researchers use memory and attention tests along with brain scans to link cognitive decline to brain tissue damage. The goal is to…
Matched conditions: MULTIPLE SCLEROSIS, PRIMARY PROGRESSIVE
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated May 26, 2026 09:37 UTC